ABOUT US

TECHNOLOGY

PIPELINE

PARTNERSHIP

NEWS AND EVENTS

CAREERS

CONTACT US

ABOUT US

home
OUR HISTORY
2023
  • SEP Phase 2 IND approval for 'SNB-101' in KR
2022
  • DEC Signed an License Out agreement of 'SNA-001' in KR (Boryung Corp.)
2021
  • APR Granted US Patent for 'SNB-101'
  • MAR Granted EU Patent for 'SNB-101'
  • FEB Signed an exclusive sales agreement of 'SNB-101' in KR (Boryung Pharmaceutical Co.,Ltd.)
2020
  • JUN Series B Funding 11 million USD (VCs)
  • JUN First phase 1 IND approval for 'SNB-101' in US
  • APR Awarded government grant for clinical trials by Ministry of Trade, Industry and Energy
  • MAR Granted KR Patent for 'SNB-101'
  • FEB First phase 1 IND approval for 'SNB-101' in KR
  • JAN Selected for Nano-medicine Research Project of National Cancer Institute (NCI, NCL)
2019
  • DEC Relocation of Headquarter (Seongnam-si Pangyo)
  • MAY Relocation of R&D center (Seongnam-si Pangyo)
  • JAN Series A Funding 6 million USD (OCI Inc., VCs)
2018
  • APR Awarded government grant for preclinical study by Ministry of Health and Welfare
  • JAN Certified as Venture Company
2017
  • NOV Awarded government grant for start-up by Ministry of SMEs and Startups
  • NOV Seed Round Funding (Hugel Inc.)
  • NOV Certified as Corporate Research Institute
  • MAY SN BioScience Inc. establishment